Status:
ACTIVE_NOT_RECRUITING
The University of Zimbabwe College of Health Science (UZ-CHS) BIRTH COHORT Study
Lead Sponsor:
University of Zimbabwe
Collaborating Sponsors:
Insel Gruppe AG, University Hospital Bern
University of Hamburg-Eppendorf
Conditions:
HIV Infections
Immune Activation
Eligibility:
FEMALE
15+ years
Brief Summary
Background Commencement of lifelong highly active antiretroviral therapy (HAART) immediately after HIV diagnosis (option B+), for treatment of human immunodeficiency virus (HIV), has greatly improved ...
Detailed Description
Over one million infants are born to HIV-1-infected women every year in Sub Saharan Africa. In Zimbabwe, annual births stand at 379,000 with approximately 48,000 infants being born every year to HIV-1...
Eligibility Criteria
Inclusion
- Consenting pregnant woman of Bantu origin of ≥15 years of age, at least 20 weeks of gestation at enrolment and planning to deliver at any of the 4 study sites, Kuwadzana, Rujeko, Glenview or Budiriro. Mothers should be willing to be followed together with their babies from delivery, and willing to provide the required data and biological specimens in follow-up visits for two years.
Exclusion
- Presence of severe maternal mental disorders.
Key Trial Info
Start Date :
January 26 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2035
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04087239
Start Date
January 26 2016
End Date
December 31 2035
Last Update
July 18 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.